{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:17:28Z","timestamp":1792592248715,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.mpmed.2010.08.008","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T11:07:26Z","timestamp":1287745646000},"page":"597-601","source":"Crossref","is-referenced-by-count":49,"title":["What is type 2 diabetes?"],"prefix":"10.1016","volume":"38","author":[{"given":"Galina","family":"Smushkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mpmed.2010.08.008_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the diagnosis and classification of diabetes mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00125-006-0348-7","article-title":"Declassifying diabetes","volume":"49","author":"Gale","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.mpmed.2010.08.008_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/diabetes.52.1.38","article-title":"Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia","volume":"52","author":"Shah","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.283.5.601","article-title":"Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus","volume":"283","author":"Davidson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.mpmed.2010.08.008_bib6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.21.9.1408","article-title":"Effects of changing diagnostic criteria on the risk of developing diabetes","volume":"21","author":"Dinneen","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib7","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.85.11.4053","article-title":"Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus","volume":"85","author":"Shah","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mpmed.2010.08.008_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/ars.2007.1610","article-title":"Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress","volume":"9","author":"Hayden","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"suppl 1","key":"10.1016\/j.mpmed.2010.08.008_bib9","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.2337\/diabetes.51.2007.S245","article-title":"Pulsatile insulin secretion: detection, regulation, and role in diabetes","volume":"51","author":"Porksen","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198805123181902","article-title":"Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes","volume":"318","author":"O\u2019Rahilly","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mpmed.2010.08.008_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","article-title":"TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program","volume":"355","author":"Florez","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mpmed.2010.08.008_bib12","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.2337\/db06-0319","article-title":"Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and\/or impaired glucose tolerance","volume":"55","author":"Bock","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MCO.0b013e32833a558d","article-title":"Genetics of type 2 diabetes","volume":"13","author":"Smushkin","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.mco.0000172588.47811.63","article-title":"The regulation of glucose effectiveness: how glucose modulates its own production","volume":"8","author":"Tonelli","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2337\/diabetes.46.3.421","article-title":"Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol","volume":"46","author":"Basu","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1172\/JCI5479","article-title":"The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects","volume":"103","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mpmed.2010.08.008_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsboll","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00125-007-0899-2","article-title":"Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and\/or impaired glucose tolerance in the EUGENE2 study","volume":"51","author":"Laakso","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.mpmed.2010.08.008_bib19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mpmed.2010.08.008_bib20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mpmed.2010.08.008_bib21","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mpmed.2010.08.008_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mpmed.2010.08.008_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF00400196","article-title":"Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study","volume":"34","author":"Eriksson","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.mpmed.2010.08.008_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0197-2456(03)00064-3","article-title":"Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes","volume":"24","author":"Ryan","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.mpmed.2010.08.008_bib25","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/dc07-0048","article-title":"Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial","volume":"30","author":"Pi-Sunyer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diabetes.55.02.06.db05-1066","article-title":"Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes","volume":"55","author":"Xiang","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib27","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib28","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.mpmed.2010.08.008_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-144-5-200603070-00011","article-title":"Narrative review: ketosis-prone type 2 diabetes mellitus","volume":"144","author":"Umpierrez","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mpmed.2010.08.008_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.med.051308.105148","article-title":"Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action","volume":"61","author":"Rubino","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.mpmed.2010.08.008_bib31","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/dc06-1499","article-title":"Risk of diabetes associated with prescribed glucocorticoids in a large population","volume":"29","author":"Gulliford","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mpmed.2010.08.008_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-54-1-131","article-title":"Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action","volume":"54","author":"Rizza","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mpmed.2010.08.008_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diabet.2007.01.003","article-title":"Abnormal glucose metabolism in patients treated with antipsychotics","volume":"33","author":"Scheen","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.mpmed.2010.08.008_bib34","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-2277.2008.00800.x","article-title":"New-onset diabetes mellitus after solid organ transplantation","volume":"22","author":"Bodziak","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.mpmed.2010.08.008_bib36","first-page":"1801","article-title":"Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats","volume":"19","author":"Yagisawa","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.mpmed.2010.08.008_bib37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/diabetes.35.9.1049","article-title":"Direct effects of cyclosporin A on human pancreatic beta-cells","volume":"35","author":"Nielsen","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.mpmed.2010.08.008_bib39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.mpmed.2010.08.008_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00592-009-0112-9","article-title":"Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities","volume":"46","author":"Resmini","year":"2009","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.mpmed.2010.08.008_bib41","article-title":"Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma","volume":"106","author":"Stenstrom","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.mpmed.2010.08.008_bib42","first-page":"123","article-title":"Severe hypoglycemia after resection of adrenal pheochromocytoma: a case report","volume":"55","author":"Umeda","year":"2009","journal-title":"Hinyokika Kiyo"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357303910002094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357303910002094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T08:54:38Z","timestamp":1544172878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357303910002094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1357303910002094"],"URL":"https:\/\/doi.org\/10.1016\/j.mpmed.2010.08.008","relation":{},"ISSN":["1357-3039"],"issn-type":[{"value":"1357-3039","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}